RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS (Details 1) - USD ($) shares in Thousands, $ in Thousands |
Mar. 31, 2026 |
Mar. 31, 2025 |
|---|---|---|
| Previously stated [member] | ||
| IfrsStatementLineItems [Line Items] | ||
| Total accounts payable and accrued liabilities | $ 5,504 | |
| Stock options exercisable, end of period | 2,246,507 | |
| Share-based compensation expense, approximate | $ 2,300 | |
| Ordinary shares repurchased | 1,196,295 | |
| Pre-funded warrants repurchased | 633,931 | |
| Short-term employee benefits (salary, bonus, etc.) | $ 13,787 | |
| As Restated [Member] | ||
| IfrsStatementLineItems [Line Items] | ||
| Total accounts payable and accrued liabilities | $ 4,146 | |
| Stock options exercisable, end of period | 1,350,947 | |
| Share-based compensation expense, approximate | $ 1,700 | |
| Ordinary shares repurchased | 1,095,000 | |
| Pre-funded warrants repurchased | 724,133 | |
| Short-term employee benefits (salary, bonus, etc.) | $ 1,378 |